1-7 of 7
Abderrazak El Yamani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preemptive Therapy with Venetoclax for High-Risk Stage a CLL Patients: First Analysis of Prevene, a Phase II Trial of the Filo Group

Luc-Matthieu Fornecker, Rémi Letestu, Nanthara Shritaran, Emmanuelle Ferrant, Fressia Honeyman, Therese Aurran-Schleinitz, Fatiha Merabet, Pierre Morel, Abderrazak El Yamani, Jehan Dupuis, Kamel Laribi, Stephane Lepretre, Lysiane Molina, Hugo Legendre, Chadi Al Nawakil, Bruno Villemagne, Anne-Sophie Michallet, Béatrice Mahé, Omar Benbrahim, Laurence Sanhes, Caroline Dartigeas, Aline Clavert, Vincent Levy
Journal: Blood
Blood (2024) 144 (Supplement 1): 3256.
https://doi.org/10.1182/blood-2024-203081
Published: 2024
Journal Articles

The IFM2017-03 Phase 3 Trial: A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide for Frail Patients with Newly-Diagnosed Multiple Myeloma

Salomon Manier, Jérome Lambert, Cyrille Hulin, Kamel Laribi, Carla Araujo, Gian Matteo Pica, Cyrille Touzeau, Pascal Godmer, Bohrane Slama, Lionel Karlin, Frederique Orsini Piocelle, Mamoun Dib, Magaret Macro, Laurence Sanhes, Lydia Montes, Abderrazak El Yamani, Mourad Tiab, Reza Tabrizi, Laurent Garderet, Bruno Royer, Benoit Bareau, Aurore Perrot, Jean Yves Mary, Jill Corre, Herve Avet Loiseau, Philippe Moreau, Xavier Leleu, Thierry Facon
Journal: Blood
Blood (2024) 144 (Supplement 1): 774.
https://doi.org/10.1182/blood-2024-203045
Published: 2024
Journal Articles

Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study

Cyrille Hulin, Aurore Perrot, Margaret Macro, Anne Vekhoff, Xavier Leleu, Lionel Karlin, Salomon Manier, Laure Vincent, Abderrazak El Yamani, Wajed Abarah, Régis Kaphan, Charles Zarnitsky, Daniel Re, Laure Christophe, Olivier Fitoussi, Nathalie Texier, Raphael Germain, Marion Willaime, Olivier Decaux
Journal: Blood
Blood (2022) 140 (Supplement 1): 7133–7135.
https://doi.org/10.1182/blood-2022-159424
Published: 2022
Journal Articles

Preliminary Study of Ruxolitinib and Venetoclax for Treatment of Patients with T-Cell Prolymphocytic Leukemia Refractory to, or Ineligible for Alemtuzumab

Charles Herbaux, Stéphanie Poulain, Damien Roos-Weil, Jacques-Olivier Bay, Yann Guillermin, Francois Lemonnier, Kamel Laribi, Sorin Visanica, Jerome Moreaux, Hugo Gonzalez, Maxime Jullien, Abderrazak El Yamani, Houria Debarri, Sophie Godet, Franck Morschhauser, Olivier Tournilhac, Matthew S. Davids, Loic Ysebaert
Journal: Blood
Blood (2021) 138 (Supplement 1): 1201.
https://doi.org/10.1182/blood-2021-149228
Published: 2021
Journal Articles

Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network

Sylvain Choquet, MD, Caroline Houillier, MD, Fontanet Bijou, MD, Roch Houot, MD PhD, Eileen Boyle, MD, Remy Gressin, MD, Emmanuelle Nicolas-Virelizier, MD, Maryline Barrie, MD, Cecile Molucon-Chabrot, MD, Marie Blonski, MD, Abderrazak El Yamani, MD, Marie-Laure LeLez, MD, Aline Clavert, MD, Solène Coisy, MD, Marjan Ertault de la Bretonnière, MD, Valérie Touitou, MD PhD, Nathalie Cassoux, MD PhD, Sami Boussetta, Florence Broussais, MD, Benedicte Gelas-Dore, Noélie Barzic, Herve Ghesquieres, MD PhD, Khê Hoang-Xuan, MD PhD, Carole Soussain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 784.
https://doi.org/10.1182/blood.V128.22.784.784
Published: 2016
Journal Articles

Final Results of the RiPAD+C Regimen Including Velcade In Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.

Remy Gressin, MD, Roch Houot, Mario Ojeda Uribe, Christiane Mounier, Krimo Bouabdallah, Magda Alexis, MD, Delphine Senecal, Marie Pierre Molles, Olivier Tournilhac, MD, PhD, Sophie Park, Philippe Rodon, MD, Abderrazak El Yamani, Laurent Sutton, Bruno Lioure, David Assouline, MD, Jean-Luc Harousseau, Hervé Maisonneuve, Sylvie Caulet Maugendre, Steven Le Gouill
Journal: Blood
Blood (2010) 116 (21): 2791.
https://doi.org/10.1182/blood.V116.21.2791.2791
Published: 2010
Journal Articles

Interim Results of the RiPAD+C Regimen Including Velcade in Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.

Remy Gressin, MD, Sylvie caulet Maugendre, MD, Steven Le Gouill, MD, Mario ojeda Uribe, MD, Magda Alexis Vigier, MD, Krimo Bouabdallah, Christiane Mounier, Olivier Tournilhac, MD, Philippe Rodon, MD, Abderrazak El Yamani, Laurent Sutton, Delphine Senecal, MD, Bruno Lioure, MD, David Assouline, MD, Annie Le Mevel, MD, Bruno Villemagne, MD, Charles Dauriac, MD, Martine Gardembas, MD, Sophie Park, MD, Thierry Lamy, PhD
Journal: Blood
Blood (2008) 112 (11): 1575.
https://doi.org/10.1182/blood.V112.11.1575.1575
Published: 2008